Glob Bioenergi
Global Bioenergies SA is in the process of liquidation. Previously, the company was engaged in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company was incorporated in 2008 and is headquartered in Évry, France.
Glob Bioenergi (ALGBE) - Total Liabilities
Latest total liabilities as of December 2024: €7.96 Million EUR
Based on the latest financial reports, Glob Bioenergi (ALGBE) has total liabilities worth €7.96 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Glob Bioenergi - Total Liabilities Trend (2008–2024)
This chart illustrates how Glob Bioenergi's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Glob Bioenergi Competitors by Total Liabilities
The table below lists competitors of Glob Bioenergi ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ARCADIS
MU:HIJ2
|
Germany | €2.72 Billion |
|
DALDRUP&SOEHNE
MU:4DS
|
Germany | €20.54 Million |
|
UNITED NATURAL FDS
BE:UN3
|
Germany | €5.89 Billion |
|
SCOR SE (SDRC.SG)
STU:SDRC
|
Germany | €30.97 Billion |
|
CAREER EDUCATION
MU:CE1
|
Germany | €178.72 Million |
|
Lachish
TA:LHIS
|
Israel | ILA46.19 Million |
|
CARTER
MU:HCH
|
Germany | €1.55 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Glob Bioenergi's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.03 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.82 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Glob Bioenergi's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Glob Bioenergi (2008–2024)
The table below shows the annual total liabilities of Glob Bioenergi from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €7.96 Million | +1.42% |
| 2023-12-31 | €7.85 Million | -43.66% |
| 2022-12-31 | €13.93 Million | +6.15% |
| 2021-12-31 | €13.12 Million | -39.44% |
| 2020-12-31 | €21.67 Million | +18.78% |
| 2019-12-31 | €18.24 Million | -4.78% |
| 2018-12-31 | €19.16 Million | +11.81% |
| 2017-12-31 | €17.13 Million | +5.48% |
| 2016-12-31 | €16.24 Million | +13.49% |
| 2015-12-31 | €14.31 Million | +133.38% |
| 2014-12-31 | €6.13 Million | +126.86% |
| 2013-12-31 | €2.70 Million | -5.35% |
| 2012-12-31 | €2.86 Million | +54.62% |
| 2011-12-31 | €1.85 Million | +135.59% |
| 2010-12-31 | €784.00K | +14.62% |
| 2009-12-31 | €684.00K | +432.27% |
| 2008-12-31 | €128.51K | -- |